WI SB759 | 2019-2020 | Regular Session

Status

Completed Legislative Action
Spectrum: Slight Partisan Bill (Republican 5-3)
Status: Failed on April 1 2020 - 100% progression
Action: 2020-04-01 - Failed to pass pursuant to Senate Joint Resolution 1
Text: Latest bill text (Introduced) [PDF]

Summary

An Act to renumber and amend 255.07 (2); to amend 118.292 (title), 118.292 (1r) (intro.) and (a) and (2) (a) and (b), 118.2925 (title), 118.2925 (1) (a), 118.2925 (1) (h), 118.2925 (3), 118.2925 (4) (title), (a), (b) and (c), 118.2925 (4m) (a) and (b), 118.2925 (5), 255.07 (title) and (1) (a), 255.07 (3), 255.07 (4), 255.07 (5) (a) 2. and 3., 255.07 (6) (a) (intro.), 1., 2. and 3., (b), (d), (e) and (f), 448.03 (2) (q) and 450.11 (4) (a) 5. d.; and to create 118.292 (1g) (bm), 118.2925 (1) (fm), 255.07 (1) (e) and 255.07 (2) (b) of the statutes; Relating to: use of epinephrine prefilled syringes and standing order for epinephrine. (FE)

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Use of epinephrine prefilled syringes and standing order for epinephrine. (FE)

Sponsors


History

DateChamberAction
2020-04-01SenateFailed to pass pursuant to Senate Joint Resolution 1
2020-02-26SenateFiscal estimate received
2020-02-14SenateFiscal estimate received
2020-02-05SenateFiscal estimate received
2020-01-30SenateRepresentative Wichgers added as a cosponsor
2020-01-29SenateRead first time and referred to Committee on Health and Human Services
2020-01-29SenateIntroduced

Wisconsin State Sources


Bill Comments

feedback